{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T13:25:30Z","timestamp":1787750730441,"version":"build-2784847793"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Imaging"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s40644-019-0206-8","type":"journal-article","created":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T14:03:34Z","timestamp":1554127414000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Investigating the diagnostic value of quantitative parameters based on T2-weighted and contrast-enhanced MRI with psoas muscle and outer myometrium as internal references for differentiating uterine sarcomas from leiomyomas at 3T MRI"],"prefix":"10.1186","volume":"19","author":[{"given":"Mahrooz","family":"Malek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Rahmani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyyedeh Mahdieh","family":"Seyyed Ebrahimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elnaz","family":"Tabibian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azadeh","family":"Alidoosti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pariya","family":"Rahimifar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Setareh","family":"Akhavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziba","family":"Gandomkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,1]]},"reference":[{"key":"206_CR1","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.ygyno.2009.09.023","volume":"116","author":"E D'Angelo","year":"2010","unstructured":"D'Angelo E, Prat J. Uterine sarcomas: a review. Gynecol Oncol. 2010;116:131\u20139.","journal-title":"Gynecol Oncol"},{"key":"206_CR2","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2147\/IJWH.S51083","volume":"6","author":"AT Khan","year":"2014","unstructured":"Khan AT, Shehmar M, Gupta JK. Uterine fibroids: current perspectives. Int J Women's Health. 2014;6:95.","journal-title":"Int J Women's Health"},{"key":"206_CR3","volume-title":"Differentiating uterine leiomyomas (fibroids) from uterine sarcomas","author":"EA Stewart","year":"2015","unstructured":"Stewart EA, Barbieri RL, Goff B, Falcone T, Falk SJ. Differentiating uterine leiomyomas (fibroids) from uterine sarcomas. Waltham: UpToDate; 2015. Accessed on 10 November 2015"},{"key":"206_CR4","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1472-6874-12-6","volume":"12","author":"A Zimmermann","year":"2012","unstructured":"Zimmermann A, Bernuit D, Gerlinger C, Schaefers M, Geppert K. Prevalence, symptoms and management of uterine fibroids: an international internet-based survey of 21,746 women. BMC Womens Health. 2012;12:6\u20136.","journal-title":"BMC Womens Health"},{"key":"206_CR5","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2147\/IJWH.S51083","volume":"6","author":"AT Khan","year":"2014","unstructured":"Khan AT, Shehmar M, Gupta JK. Uterine fibroids: current perspectives. Int J Women's Health. 2014;6:95\u2013114.","journal-title":"Int J Women's Health"},{"key":"206_CR6","first-page":"3601","volume":"61","author":"SJ Smith","year":"2000","unstructured":"Smith SJ. Uterine fibroid embolization. Am Fam Physician. 2000;61:3601\u201314.","journal-title":"Am Fam Physician"},{"key":"206_CR7","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/0046-8177(93)90186-K","volume":"24","author":"TJ Colgan","year":"1993","unstructured":"Colgan TJ, Pendergast S, LeBlanc M. The histopathology of uterine leiomyomas following treatment with gonadotropin-releasing hormone analogues. Hum Pathol. 1993;24:1073\u20137.","journal-title":"Hum Pathol"},{"key":"206_CR8","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/0002-9378(90)91298-Q","volume":"162","author":"S Leibsohn","year":"1990","unstructured":"Leibsohn S, d'Ablaing G, Mishell DR, Schlaerth JB. Leiomyosarcoma in a series of hysterectomies performed for presumed uterine leiomyomas. Am J Obstet Gynecol. 1990;162:968\u201376.","journal-title":"Am J Obstet Gynecol"},{"key":"206_CR9","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ygyno.2008.02.026","volume":"110","author":"N Bansal","year":"2008","unstructured":"Bansal N, Herzog TJ, Burke W, Cohen CJ, Wright JD. The utility of preoperative endometrial sampling for the detection of uterine sarcomas. Gynecol Oncol. 2008;110:43\u20138.","journal-title":"Gynecol Oncol"},{"key":"206_CR10","first-page":"237","volume":"24","author":"P Morice","year":"2003","unstructured":"Morice P, Rodriguez A, Rey A, Pautier P, Atallah D, Genestie C, Pomel C, Lhomm\u00e9 C, Haie-Meder C, Duvillard P. Prognostic value of initial surgical procedure for patients with uterine sarcoma: analysis of 123 patients. Eur J Gynaecol Oncol. 2003;24:237\u201340.","journal-title":"Eur J Gynaecol Oncol"},{"key":"206_CR11","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/IGC.0b013e31819a1f8f","volume":"19","author":"T Perri","year":"2009","unstructured":"Perri T, Korach J, Sadetzki S, Oberman B, Fridman E, Ben-Baruch G. Uterine leiomyosarcoma: does the primary surgical procedure matter? Int J Gynecol Cancer. 2009;19:257\u201360.","journal-title":"Int J Gynecol Cancer"},{"key":"206_CR12","doi-asserted-by":"publisher","first-page":"3154","DOI":"10.1002\/cncr.28844","volume":"120","author":"S George","year":"2014","unstructured":"George S, Barysauskas C, Serrano C, Oduyebo T, Rauh-Hain JA, Del Carmen MG, Demetri GD, Muto MG. Retrospective cohort study evaluating the impact of intraperitoneal morcellation on outcomes of localized uterine leiomyosarcoma. Cancer. 2014;120:3154\u20138.","journal-title":"Cancer"},{"key":"206_CR13","first-page":"656","volume":"33","author":"G Carta","year":"2012","unstructured":"Carta G, Palermo P, Di Ramio R, De Lellis V, Carta A, Patacchiola F. Leiomyosarcoma after hysteroscopic myomectomy: a case report. Eur J Gynaecol Oncol. 2012;33:656\u20137.","journal-title":"Eur J Gynaecol Oncol"},{"key":"206_CR14","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.2214\/ajr.177.6.1771307","volume":"177","author":"A Sahdev","year":"2001","unstructured":"Sahdev A, Sohaib S, Jacobs I, Shepherd J, Oram D, Reznek R. MR imaging of uterine sarcomas. Am J Roentgenol. 2001;177:1307\u201311.","journal-title":"Am J Roentgenol"},{"key":"206_CR15","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.2214\/ajr.158.5.1566664","volume":"158","author":"H Hricak","year":"1992","unstructured":"Hricak H, Finck S, Honda G, Goranson H. MR imaging in the evaluation of benign uterine masses: value of gadopentetate dimeglumine-enhanced T1-weighted images. AJR Am J Roentgenol. 1992;158:1043\u201350.","journal-title":"AJR Am J Roentgenol"},{"key":"206_CR16","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1148\/radiographics.19.5.g99se131179","volume":"19","author":"E Murase","year":"1999","unstructured":"Murase E, Siegelman ES, Outwater EK, Perez-Jaffe LA, Tureck RW. Uterine leiomyomas: histopathologic features, MR imaging findings, differential diagnosis, and treatment. Radiographics. 1999;19:1179\u201397.","journal-title":"Radiographics"},{"key":"206_CR17","doi-asserted-by":"publisher","first-page":"S131","DOI":"10.1148\/radiographics.19.suppl_1.g99oc04s131","volume":"19","author":"H Ueda","year":"1999","unstructured":"Ueda H, Togashi K, Konishi I, Kataoka ML, Koyama T, Fujiwara T, Kobayashi H, Fujii S, Konishi J. Unusual appearances of uterine leiomyomas: MR imaging findings and their histopathologic backgrounds. Radiographics. 1999;19:S131\u201345.","journal-title":"Radiographics"},{"key":"206_CR18","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/S0015-0282(98)00193-9","volume":"70","author":"LB Schwartz","year":"1998","unstructured":"Schwartz LB, Zawin M, Carcangiu ML, Lange R, McCarthy S. Does pelvic magnetic resonance imaging differentiate among the histologic subtypes of uterine leiomyomata? Fertil Steril. 1998;70:580\u20137.","journal-title":"Fertil Steril"},{"key":"206_CR19","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1007\/s00330-013-2819-9","volume":"23","author":"I Thomassin-Naggara","year":"2013","unstructured":"Thomassin-Naggara I, Dechoux S, Bonneau C, Morel A, Rouzier R, Carette M-F, Dara\u00ef E, Bazot M. How to differentiate benign from malignant myometrial tumours using MR imaging. Eur Radiol. 2013;23:2306\u201314.","journal-title":"Eur Radiol"},{"key":"206_CR20","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.ajog.2013.12.028","volume":"210","author":"K Sato","year":"2014","unstructured":"Sato K, Yuasa N, Fujita M, Fukushima Y. Clinical application of diffusion-weighted imaging for preoperative differentiation between uterine leiomyoma and leiomyosarcoma. Am J Obstet Gynecol. 2014;210:368 e361\u2013368. e368.","journal-title":"Am J Obstet Gynecol"},{"key":"206_CR21","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1097\/AOG.0000000000001157","volume":"127","author":"WH Parker","year":"2016","unstructured":"Parker WH, Kaunitz AM, Pritts EA, Olive DL, Chalas E, Clarke-Pearson DL, Berek JS. US Food and Drug Administration's guidance regarding morcellation of leiomyomas: well-intentioned, but is it harmful for women? Obstet Gynecol. 2016;127:18\u201322.","journal-title":"Obstet Gynecol"},{"key":"206_CR22","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.1007\/s00330-009-1471-x","volume":"19","author":"T Namimoto","year":"2009","unstructured":"Namimoto T, Yamashita Y, Awai K, Nakaura T, Yanaga Y, Hirai T, Saito T, Katabuchi H. Combined use of T2-weighted and diffusion-weighted 3-T MR imaging for differentiating uterine sarcomas from benign leiomyomas. Eur Radiol. 2009;19:2756.","journal-title":"Eur Radiol"},{"key":"206_CR23","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1002\/jmri.24119","volume":"38","author":"JS Carter","year":"2013","unstructured":"Carter JS, Koopmeiners JS, Kuehn-Hajder JE, Metzger GJ, Lakkadi N, Downs LS, Bolan PJ. Quantitative multiparametric MRI of ovarian cancer. J Magn Reson Imaging. 2013;38:1501\u20139.","journal-title":"J Magn Reson Imaging"},{"key":"206_CR24","volume":"13","author":"L Liu","year":"2016","unstructured":"Liu L, Yin B, Geng DY, Lu YP, Peng WJ. Changes of T2 relaxation time from neoadjuvant chemotherapy in breast Cancer lesions. Iran J Radiol. 2016;13:e24014.","journal-title":"Iran J Radiol"},{"key":"206_CR25","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.jvir.2017.02.003","volume":"28","author":"SH Kang","year":"2017","unstructured":"Kang SH, Lee SJ, Jeon GS, Yoon S-W. Scaled signal intensity of uterine fibroids on T2-weighted MR imaging as a predictor of the potential response to uterine fibroid embolization. J Vasc Interv Radiol. 2017;28:844\u20139.","journal-title":"J Vasc Interv Radiol"},{"key":"206_CR26","doi-asserted-by":"publisher","first-page":"295","DOI":"10.2463\/mrms.2014-0023","volume":"14","author":"A SUMI","year":"2015","unstructured":"SUMI A, TERASAKI H, SANADA S, UCHIDA M, TOMIOKA Y, KAMURA T, YANO H, ABE T. Assessment of MR imaging as a tool to differentiate between the major histological types of uterine sarcomas. Magn Reson Med Sci. 2015;14:295\u2013304.","journal-title":"Magn Reson Med Sci"},{"key":"206_CR27","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1148\/radiology.161.2.3532190","volume":"161","author":"DR Haynor","year":"1986","unstructured":"Haynor DR, Mack LA, Soules MR, Shuman W, Montana M, Moss A. Changing appearance of the normal uterus during the menstrual cycle: MR studies. Radiology. 1986;161:459\u201362.","journal-title":"Radiology"},{"key":"206_CR28","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/S0009-9260(97)80300-5","volume":"52","author":"H Seki","year":"1997","unstructured":"Seki H, Kimura M, Sakai K. Myometrial invasion of endometrial carcinoma: Assessment with dynamic MR and contrast-enhanced T1-weighted images. Clin Radiol. 1997;52:18\u201323.","journal-title":"Clin Radiol"},{"key":"206_CR29","doi-asserted-by":"publisher","first-page":"276","DOI":"10.11613\/BM.2012.031","volume":"22","author":"ML McHugh","year":"2012","unstructured":"McHugh ML. Interrater reliability: the kappa statistic. Biochemia medica: Biochemia medica. 2012;22:276\u201382.","journal-title":"Biochemia medica: Biochemia medica"},{"key":"206_CR30","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1148\/radiology.158.2.3753623","volume":"158","author":"H Hricak","year":"1986","unstructured":"Hricak H, Tscholakoff D, Heinrichs L, Fisher M, Dooms G, Reinhold C, Jaffe R. Uterine leiomyomas: correlation of MR, histopathologic findings, and symptoms. Radiology. 1986;158:385\u201391.","journal-title":"Radiology"},{"key":"206_CR31","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1148\/radiology.171.2.2704819","volume":"171","author":"K Togashi","year":"1989","unstructured":"Togashi K, Ozasa H, Konishi I, Itoh H, Nishimura K, Fujisawa I, Noma S, Sagoh T, Minami S, Yamashita K. Enlarged uterus: differentiation between adenomyosis and leiomyoma with MR imaging. Radiology. 1989;171:531\u20134.","journal-title":"Radiology"},{"key":"206_CR32","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1097\/00004728-199309000-00018","volume":"17","author":"H Okizuka","year":"1993","unstructured":"Okizuka H, Sugimura K, Takemori M, Obayashi C, Kitao M, Ishida T. MR detection of degenerating uterine leiomyomas. J Comput Assist Tomogr. 1993;17:760\u20136.","journal-title":"J Comput Assist Tomogr"},{"key":"206_CR33","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.diii.2014.11.016","volume":"96","author":"A Hoang Dinh","year":"2015","unstructured":"Hoang Dinh A, Souchon R, Melodelima C, Bratan F, M\u00e8ge-Lechevallier F, Colombel M, Rouvi\u00e8re O. Characterization of prostate cancer using T2 mapping at 3T: a multi-scanner study. Diagn Interv Imaging. 2015;96:365\u201372.","journal-title":"Diagn Interv Imaging"},{"key":"206_CR34","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/jmri.24998","volume":"43","author":"G Lin","year":"2016","unstructured":"Lin G, Yang LY, Huang YT, Ng KK, Ng SH, Ueng SH, Chao A, Yen TC, Chang TC, Lai CH. Comparison of the diagnostic accuracy of contrast-enhanced MRI and diffusion-weighted MRI in the differentiation between uterine leiomyosarcoma\/smooth muscle tumor with uncertain malignant potential and benign leiomyoma. J Magn Reson Imaging. 2016;43:333\u201342.","journal-title":"J Magn Reson Imaging"},{"key":"206_CR35","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.ejrad.2018.11.009","volume":"110","author":"M Malek","year":"2019","unstructured":"Malek M, Gity M, Alidoosti A, Oghabian Z, Rahimifar P, Ebrahimi SMS, Tabibian E, Oghabian MA. A machine learning approach for distinguishing uterine sarcoma from leiomyomas based on perfusion weighted MRI parameters. Eur J Radiol. 2019;110:203\u201311.","journal-title":"Eur J Radiol"}],"container-title":["Cancer Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-019-0206-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40644-019-0206-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-019-0206-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,30]],"date-time":"2020-03-30T23:16:15Z","timestamp":1585610175000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancerimagingjournal.biomedcentral.com\/articles\/10.1186\/s40644-019-0206-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["206"],"URL":"https:\/\/doi.org\/10.1186\/s40644-019-0206-8","relation":{},"ISSN":["1470-7330"],"issn-type":[{"value":"1470-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,1]]},"assertion":[{"value":"8 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The institutional ethics committee approved the study protocol.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"20"}}